Close

Ratings by Morgan Stanley (Matthew Harrison)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2022 Editas Medicine EDIT Maintain Underweight
(N/A)
 
 
  Details
11/14/2022 Prime Medicine PRME New Coverage Equalweight
(N/A)
21.12
(18.20)
-13.83% Details
11/14/2022 Lyell Immunopharma LYEL Downgrade Equalweight
(Overweight)
4.96
(4.24)
-14.52% Details
11/4/2022 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
11/3/2022 Regeneron Pharma REGN Maintain Overweight
(N/A)
 
 
  Details
10/27/2022 Bristol-Myers Squibb Co. BMY Maintain Underweight
(N/A)
 
 
  Details
10/27/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
10/18/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
10/13/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
10/13/2022 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
10/13/2022 Legand Biotech Corp. LEGN Maintain Overweight
(N/A)
 
 
  Details
10/13/2022 Inova Technology, Inc. INVA Maintain Underweight
(N/A)
 
 
  Details
10/13/2022 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
10/13/2022 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
10/13/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
10/13/2022 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/13/2022 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
10/12/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
10/11/2022 Artivion Inc. AORT Maintain Equalweight
(N/A)
 
 
  Details
10/11/2022 Amgen AMGN Upgrade Overweight
(Equalweight)
232.15
(280.82)
20.96% Details
9/27/2022 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
9/9/2022 Adagene Inc ADAG Maintain Overweight
(N/A)
 
 
  Details
9/9/2022 Galapagos NV GLPG Downgrade Equalweight
(Overweight)
48.24
(39.77)
-17.56% Details
9/9/2022 Alector Inc. ALEC Downgrade Equalweight
(Overweight)
10.72
(7.55)
-29.57% Details
9/9/2022 ADC Therapeutics ADCT Downgrade Equalweight
(Overweight)
6.16
(3.42)
-44.48% Details
9/9/2022 Regeneron Pharma REGN Upgrade Overweight
(Equalweight)
596.44
(727.99)
22.06% Details
9/8/2022 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
9/6/2022 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
8/23/2022 Pharvaris B.V. PHVS Downgrade Equalweight
(Overweight)
18.49
(2.22)
-87.99% Details
8/22/2022 Cerevel Therapeutics CERE Maintain Overweight
(N/A)
 
 
  Details
8/12/2022 Centessa Pharmaceuticals CNTA Downgrade Underweight
(Overweight)
4.75
(4.03)
-15.16% Details
8/8/2022 Royalty Pharma RPRX Maintain Overweight
(N/A)
 
 
  Details
8/8/2022 Inova Technology, Inc. INVA Maintain Underweight
(N/A)
 
 
  Details
8/8/2022 Artivion Inc. AORT Maintain Equalweight
(N/A)
 
 
  Details
8/8/2022 Alector Inc. ALEC Maintain Overweight
(N/A)
 
 
  Details
8/8/2022 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
8/4/2022 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/4/2022 Amgen AMGN Maintain Equalweight
(N/A)
 
 
  Details
8/3/2022 Alnylam Pharmaceuticals ALNY Maintain Equalweight
(N/A)
 
 
  Details
7/26/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
7/5/2022 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
6/23/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
6/22/2022 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
6/21/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
6/6/2022 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
6/2/2022 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/24/2022 Centessa Pharmaceuticals CNTA Maintain Overweight
(N/A)
 
 
  Details
5/18/2022 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
5/9/2022 ADC Therapeutics ADCT Maintain Overweight
(N/A)
 
 
  Details
5/9/2022 BioNTech BNTX Maintain Equalweight
(N/A)
 
 
  Details
5/9/2022 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
5/9/2022 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
5/9/2022 Editas Medicine EDIT Maintain Underweight
(N/A)
 
 
  Details
5/4/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
5/3/2022 Vertex VRTX Upgrade Equalweight
(Underweight)
273.22
(314.97)
15.28% Details
5/3/2022 argenx SE ARGX Upgrade Overweight
(Equalweight)
287.32
(375.36)
30.64% Details
5/2/2022 Bristol-Myers Squibb Co. BMY Maintain Underweight
(N/A)
 
 
  Details
5/2/2022 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
4/28/2022 Amgen AMGN Maintain Equalweight
(N/A)
 
 
  Details
4/26/2022 argenx SE ARGX Maintain Equalweight
(N/A)
 
 
  Details
4/25/2022 Alnylam Pharmaceuticals ALNY Downgrade Equalweight
(Overweight)
168.75
(212.05)
25.66% Details
4/25/2022 BioMarin Pharmaceutical Inc. BMRN Upgrade Overweight
(Equalweight)
80.50
(98.35)
22.17% Details
4/18/2022 Bristol-Myers Squibb Co. BMY Maintain Underweight
(N/A)
 
 
  Details
4/12/2022 Vertex VRTX Maintain Underweight
(N/A)
 
 
  Details
4/12/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
4/12/2022 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 Kodiak Sciences Inc. KOD Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 Inova Technology, Inc. INVA Maintain Underweight
(N/A)
 
 
  Details
4/12/2022 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 Fulcrum Therapeutics FULC Maintain Overweight
(N/A)
 
 
  Details
4/12/2022 Editas Medicine EDIT Maintain Underweight
(N/A)
 
 
  Details
4/12/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 Biogen BIIB Maintain Overweight
(Overweight)
 
 
  Details
4/12/2022 BioNTech BNTX Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
4/12/2022 Amgen AMGN Maintain Equalweight
(N/A)
 
 
  Details
4/12/2022 ADC Therapeutics ADCT Maintain Overweight
(N/A)
 
 
  Details
4/6/2022 Royalty Pharma RPRX Upgrade Overweight
(Equalweight)
39.74
(42.99)
8.18% Details
4/6/2022 Organon & Co. OGN Maintain Equalweight
(N/A)
 
 
  Details
4/6/2022 Merck MRK Maintain Equalweight
(N/A)
 
 
  Details
4/6/2022 Johnson & Johnson JNJ Maintain Equalweight
(N/A)
 
 
  Details
4/6/2022 Bristol-Myers Squibb Co. BMY Downgrade Underweight
(Equalweight)
73.79
(78.75)
6.72% Details
4/6/2022 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
4/5/2022 Centessa Pharmaceuticals CNTA Maintain Overweight
(N/A)
 
 
  Details
3/29/2022 Vaccitech VACC Maintain Overweight
(N/A)
 
 
  Details
3/29/2022 2Seventy Bio Inc. TSVT Maintain Overweight
(N/A)
 
 
  Details
3/25/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
3/22/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
3/15/2022 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
3/10/2022 Vertex VRTX Maintain Underweight
(N/A)
 
 
  Details
3/7/2022 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
3/7/2022 Legand Biotech Corp. LEGN Maintain Overweight
(N/A)
 
 
  Details
3/7/2022 bluebird bio BLUE Maintain Underweight
(N/A)
 
 
  Details
3/7/2022 argenx SE ARGX Maintain Equalweight
(N/A)
 
 
  Details
2/25/2022 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
2/24/2022 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
2/24/2022 Kodiak Sciences Inc. KOD Maintain Equalweight
(N/A)
 
 
  Details
2/18/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Equalweight
(N/A)
 
 
  Details
2/15/2022 argenx SE ARGX Maintain Equalweight
(N/A)
 
 
  Details
2/10/2022 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
2/10/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
2/9/2022 Amgen AMGN Maintain Equalweight
(N/A)
 
 
  Details
2/2/2022 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
2/1/2022 Vigil Neuroscience Inc VIGL New Coverage Equalweight
(N/A)
14.65
(12.04)
-17.82% Details
1/31/2022 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
1/31/2022 Seagen SGEN Upgrade Overweight
(Equalweight)
122.91
(119.69)
-2.62% Details
1/31/2022 Legand Biotech Corp. LEGN Upgrade Overweight
(Equalweight)
35.78
(49.04)
37.06% Details
1/27/2022 Vertex VRTX Maintain Underweight
(N/A)
 
 
  Details
1/24/2022 Johnson & Johnson JNJ Maintain Equalweight
(N/A)
 
 
  Details
1/24/2022 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
1/19/2022 bluebird bio BLUE Maintain Underweight
(N/A)
 
 
  Details
1/12/2022 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
1/11/2022 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
1/11/2022 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
1/6/2022 Atea Pharmaceuticals AVIR Downgrade Underweight
(Equalweight)
8.30
(4.66)
-43.86% Details
1/6/2022 Adagio ADGI Downgrade Underweight
(Equalweight)
6.50
(4.64)
-28.62% Details
1/6/2022 Bolt Biotherapeutics, Inc. BOLT Downgrade Equalweight
(Overweight)
4.20
(1.32)
-68.57% Details
1/6/2022 Legand Biotech Corp. LEGN Downgrade Equalweight
(Overweight)
46.75
(49.04)
4.9% Details
1/6/2022 Gilead Sciences GILD Downgrade Equalweight
(Overweight)
72.21
(85.23)
18.03% Details
12/16/2021 BioNTech BNTX New Coverage Equalweight
(N/A)
276.77
(164.56)
-40.54% Details
12/14/2021 Adagio ADGI Downgrade Equalweight
(Overweight)
34.26
(4.64)
-86.46% Details
11/30/2021 IO Biotech IOBT New Coverage Overweight
(N/A)
7.61
(2.93)
-61.5% Details
11/30/2021 Sigilon Therapeutics SGTX Maintain Equalweight
(N/A)
 
 
  Details
11/29/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
11/29/2021 Merck MRK Maintain Equalweight
(N/A)
 
 
  Details
11/29/2021 Adagio ADGI Upgrade Overweight
(Equalweight)
18.73
(34.26)
82.92% Details
11/23/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
11/22/2021 BioMarin Pharmaceutical Inc. BMRN Maintain Equalweight
(N/A)
 
 
  Details
11/17/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
11/8/2021 2Seventy Bio Inc. TSVT New Coverage Overweight
(N/A)
33.62
(15.25)
-54.64% Details
11/8/2021 bluebird bio BLUE Downgrade Underweight
(Equalweight)
13.14
(7.65)
-41.78% Details
11/8/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
11/8/2021 Merck MRK Maintain Equalweight
(N/A)
 
 
  Details
11/5/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
11/5/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
11/2/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
11/1/2021 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
10/29/2021 Merck MRK Maintain Equalweight
(N/A)
 
 
  Details
10/29/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
10/21/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/20/2021 Atea Pharmaceuticals AVIR Maintain Equalweight
(N/A)
 
 
  Details
10/19/2021 Freeline FRLN Maintain Overweight
(N/A)
 
 
  Details
10/19/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
10/19/2021 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Vertex VRTX Maintain Underweight
(N/A)
 
 
  Details
10/12/2021 Sage Therapeutics SAGE Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Merck MRK Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Legand Biotech Corp. LEGN Maintain Overweight
(N/A)
 
 
  Details
10/12/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
10/12/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/12/2021 Amgen AMGN Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Allovir Inc. ALVR Maintain Overweight
(N/A)
 
 
  Details
10/8/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
10/5/2021 Atea Pharmaceuticals AVIR Downgrade Equalweight
(Overweight)
42.01
(4.66)
-88.91% Details
9/14/2021 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details
9/7/2021 Cerevel Therapeutics CERE Maintain Overweight
(N/A)
 
 
  Details
9/7/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
9/7/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
9/7/2021 argenx SE ARGX Downgrade Equalweight
(Overweight)
349.07
(375.36)
7.53% Details
9/7/2021 Vertex VRTX Downgrade Underweight
(Equalweight)
199.22
(314.97)
58.1% Details
9/7/2021 Merck MRK Downgrade Equalweight
(Overweight)
77.12
(108.27)
40.39% Details
9/7/2021 Johnson & Johnson JNJ Downgrade Equalweight
(Overweight)
174.93
(175.62)
0.39% Details
9/7/2021 Genmab A/S GMAB Downgrade Underweight
(Equalweight)
48.71
(44.54)
-8.56% Details
9/7/2021 Amgen AMGN Downgrade Equalweight
(Overweight)
225.96
(232.15)
2.74% Details
8/31/2021 Adagio ADGI New Coverage Equalweight
(N/A)
30.38
(4.64)
-84.73% Details
8/27/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
8/24/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
8/24/2021 Tenaya Therapeutics Inc TNYA New Coverage Overweight
(N/A)
22.67
(2.66)
-88.27% Details
8/20/2021 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Taysha Gene Therapies TSHA Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Fusion Pharmaceuticals FUSN Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Atea Pharmaceuticals AVIR Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Allovir Inc. ALVR Maintain Overweight
(N/A)
 
 
  Details
8/16/2021 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
8/16/2021 Royalty Pharma RPRX Maintain Equalweight
(N/A)
 
 
  Details
8/16/2021 Organon & Co. OGN Maintain Equalweight
(N/A)
 
 
  Details
8/16/2021 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/16/2021 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/11/2021 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
8/11/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/11/2021 Imara Inc. IMRA Downgrade Equalweight
(Overweight)
5.90
(4.35)
-26.27% Details
8/11/2021 Fulcrum Therapeutics FULC Upgrade Overweight
(Equalweight)
8.33
(7.00)
-15.97% Details
7/29/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
7/29/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
7/23/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Sigilon Therapeutics SGTX Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Seagen SGEN Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Alector Inc. ALEC Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Adagene Inc ADAG Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 ADC Therapeutics ADCT Maintain Overweight
(N/A)
 
 
  Details
7/12/2021 Lyell Immunopharma LYEL New Coverage Overweight
(N/A)
15.25
(4.24)
-72.2% Details
6/22/2021 Centessa Pharmaceuticals CNTA New Coverage Overweight
(N/A)
24.91
(4.03)
-83.82% Details
6/18/2021 Cerevel Therapeutics CERE New Coverage Overweight
(N/A)
13.49
(28.01)
107.64% Details
6/11/2021 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
6/10/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
6/8/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
6/3/2021 BeiGene, Ltd. BGNE Maintain Overweight
(Overweight)
 
 
  Details
6/3/2021 Atea Pharmaceuticals AVIR Maintain Overweight
(Overweight)
 
 
  Details
5/25/2021 Vaccitech VACC New Coverage Overweight
(N/A)
14.58
(2.31)
-84.16% Details
5/18/2021 argenx SE ARGX Maintain Overweight
(Overweight)
 
 
  Details
5/18/2021 Fusion Pharmaceuticals FUSN Maintain Overweight
(Overweight)
 
 
  Details
5/18/2021 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(Equalweight)
 
 
  Details
5/11/2021 Galapagos NV GLPG Maintain Overweight
(Overweight)
 
 
  Details
5/10/2021 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
5/10/2021 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
5/10/2021 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
5/10/2021 Editas Medicine EDIT Maintain Underweight
(N/A)
 
 
  Details
5/10/2021 ADC Technologies ADCT Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/6/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
5/3/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(Equalweight)
 
 
  Details
4/30/2021 Vertex VRTX Maintain Equalweight
(Equalweight)
 
 
  Details
4/30/2021 Gilead Sciences GILD Maintain Overweight
(Overweight)
 
 
  Details
4/28/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
4/13/2021 Taysha Gene Therapies TSHA Maintain Overweight
(Overweight)
 
 
  Details
4/6/2021 Fusion Pharmaceuticals FUSN Maintain Overweight
(Overweight)
 
 
  Details
4/6/2021 Freeline FRLN Maintain Overweight
(Overweight)
 
 
  Details
4/6/2021 Atea Pharmaceuticals AVIR Maintain Overweight
(Overweight)
 
 
  Details
3/29/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
3/26/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
3/22/2021 Akero Therapeutics AKRO Maintain Overweight
(Overweight)
 
 
  Details
3/22/2021 ADC Technologies ADCT Maintain Overweight
(Overweight)
 
 
  Details
3/11/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
3/11/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
3/11/2021 Galapagos NV GLPG Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 argenx SE ARGX Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Taysha Gene Therapies TSHA Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Regenxbio Inc. RGNX Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Kodiak Sciences Inc. KOD Maintain Equalweight
(Equalweight)
 
 
  Details
3/8/2021 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(Equalweight)
 
 
  Details
3/8/2021 Imara Inc. IMRA Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Fulcrum Therapeutics FULC Maintain Equalweight
(Equalweight)
 
 
  Details
3/8/2021 Adagene Inc ADAG New Coverage Overweight
(N/A)
22.99
(1.02)
-95.56% Details
3/5/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
3/2/2021 Pharvaris B.V. PHVS New Coverage Overweight
(N/A)
39.23
(2.22)
-94.34% Details
3/2/2021 Sage Therapeutics SAGE Maintain Equalweight
(Equalweight)
 
 
  Details
3/2/2021 Insmed INSM Maintain Overweight
(Overweight)
 
 
  Details
3/2/2021 Editas Medicine EDIT Maintain Underweight
(Underweight)
 
 
  Details
3/2/2021 Bolt Biotherapeutics, Inc. BOLT New Coverage Overweight
(N/A)
26.70
(1.32)
-95.06% Details
3/2/2021 bluebird bio BLUE Maintain Equalweight
(Equalweight)
 
 
  Details
2/26/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
2/25/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
2/24/2021 Huntington Bancshares HBAN Maintain Equalweight
(Equalweight)
 
 
  Details
2/18/2021 Moderna MRNA Maintain Equalweight
(Equalweight)
 
 
  Details
2/17/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
2/12/2021 Seagen SGEN Maintain Equalweight
(Equalweight)
 
 
  Details
2/8/2021 Regeneron Pharma REGN Maintain Equalweight
(Equalweight)
 
 
  Details
2/5/2021 Gilead Sciences GILD Maintain Overweight
(Overweight)
 
 
  Details
2/4/2021 Biogen BIIB Maintain Overweight
(Overweight)
 
 
  Details
2/3/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
2/2/2021 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
1/26/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
1/21/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
1/19/2021 Galapagos NV GLPG Maintain Overweight
(Equalweight)
 
 
  Details
1/19/2021 BeiGene, Ltd. BGNE Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Vertex VRTX Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Regenxbio Inc. RGNX Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Regeneron Pharma REGN Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Biogen BIIB Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Seagen SGEN Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Genmab A/S GMAB Downgrade Equalweight
(Overweight)
44.12
(44.54)
0.95% Details
1/19/2021 Gilead Sciences GILD Upgrade Overweight
(Equalweight)
62.40
(85.23)
36.59% Details
1/19/2021 Silicon Labs SLAB New Coverage Equalweight
(N/A)
135.45
(138.76)
2.44% Details
1/19/2021 Editas Medicine EDIT Downgrade Underweight
(Equalweight)
75.92
(10.02)
-86.8% Details
1/8/2021 Sarepta Therapeutics SRPT Downgrade Equalweight
(Overweight)
166.45
(119.00)
-28.51% Details
12/30/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
12/29/2020 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
12/29/2020 Sigilon Therapeutics SGTX New Coverage Equalweight
(N/A)
41.20
(0.47)
-98.86% Details
12/24/2020 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
12/16/2020 Moderna MRNA Downgrade Equalweight
(Overweight)
155.07
(177.09)
14.2% Details
12/11/2020 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
12/4/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
12/1/2020 Sage Therapeutics SAGE Maintain Equalweight
(N/A)
 
 
  Details
11/16/2020 Sage Therapeutics SAGE Downgrade Equalweight
(Overweight)
78.00
(44.07)
-43.5% Details
11/16/2020 Kodiak Sciences Inc. KOD Downgrade Equalweight
(Overweight)
122.63
(7.38)
-93.98% Details
11/12/2020 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
11/11/2020 Zentalis Pharmaceuticals ZNTL Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
11/11/2020 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/11/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
11/3/2020 Gilead Sciences GILD New Coverage Equalweight
(N/A)
58.15
(85.23)
46.57% Details
10/22/2020 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Zentalis Pharmaceuticals ZNTL Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Allovir Inc. ALVR New Coverage Overweight
(N/A)
30.85
(20.92)
-32.19% Details
8/21/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
8/21/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Equalweight
(N/A)
 
 
  Details
8/12/2020 Fulcrrum Therapeutics FULC Downgrade Equalweight
(Overweight)
17.12
(7.00)
-59.11% Details
8/10/2020 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
8/10/2020 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
8/10/2020 Immunomedics IMMU Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/10/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
8/6/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
8/6/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
7/31/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
7/29/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/27/2020 Biogen BIIB Upgrade Overweight
(Equalweight)
278.51
(291.01)
4.49% Details
7/15/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Cabaletta Bio Inc. CABA Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
7/15/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
7/9/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
7/8/2020 BioMarin Pharmaceutical Inc. BMRN Downgrade Equalweight
(Overweight)
127.71
(98.35)
-22.99% Details
7/8/2020 Vertex VRTX Downgrade Equalweight
(Overweight)
291.31
(314.97)
8.12% Details
6/30/2020 Legend Biotech Corp. LEGN New Coverage Overweight
(N/A)
40.03
(49.04)
22.51% Details
5/28/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
5/28/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
5/28/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
5/27/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
5/21/2020 Kaleido Biosciences Inc. KLDO Downgrade Equalweight
(Overweight)
6.45
(0.29)
-95.5% Details
5/21/2020 Evelo Biosciences Inc EVLO Downgrade Equalweight
(Overweight)
4.32
(2.00)
-53.7% Details
5/20/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/7/2020 Immunomedics IMMU Maintain Equalweight
(N/A)
 
 
  Details
5/7/2020 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
5/7/2020 Alexion Pharmaceuticals ALXN Maintain Equalweight
(N/A)
 
 
  Details
5/6/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/4/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
5/1/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
4/28/2020 Zentalis Pharmaceuticals ZNTL New Coverage Overweight
(N/A)
30.50
(20.95)
-31.31% Details
4/23/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
4/7/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
3/3/2020 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
3/3/2020 Immunomedics IMMU Maintain Equalweight
(N/A)
 
 
  Details
3/3/2020 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
3/3/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
3/3/2020 Forty Seven Inc. FTSV Downgrade Equalweight
(Overweight)
58.00
(95.51)
64.67% Details
2/26/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
2/26/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
2/18/2020 Evelo Biosciences Inc EVLO Maintain Overweight
(N/A)
 
 
  Details
2/7/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
2/7/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
2/6/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
2/4/2020 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
1/31/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
1/31/2020 Alexion Pharmaceuticals ALXN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
1/17/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
1/17/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
1/17/2020 Alexion Pharmaceuticals ALXN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 BeiGene, Ltd. BGNE New Coverage Overweight
(N/A)
167.85
(182.40)
8.67% Details
12/24/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Kodiak Sciences Inc. KOD Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
12/17/2019 Amgen AMGN New Coverage Overweight
(N/A)
243.20
(280.82)
15.47% Details
12/17/2019 Alexion Pharmaceuticals ALXN Downgrade Equalweight
(Overweight)
110.42
(182.01)
64.83% Details
12/10/2019 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
12/10/2019 Seattle Genetics SGEN New Coverage Equalweight
(N/A)
117.50
(119.69)
1.86% Details
12/6/2019 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
11/19/2019 Cabaletta Bio Inc. CABA New Coverage Overweight
(N/A)
14.00
(12.74)
-9% Details
11/11/2019 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
11/11/2019 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
11/6/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
11/5/2019 Kodiak Sciences Inc. KOD Maintain Overweight
(N/A)
 
 
  Details
11/1/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/1/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/1/2019 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
10/29/2019 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
10/28/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
10/28/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
10/23/2019 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
10/11/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Evelo Biosciences Inc EVLO Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
10/11/2019 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
10/11/2019 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Alexion Pharmaceuticals ALXN Maintain Overweight
(N/A)
 
 
  Details
9/9/2019 Galapagos NV GLPG New Coverage Overweight
(N/A)
162.04
(39.77)
-75.46% Details
9/6/2019 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
9/5/2019 Incyte INCY New Coverage Equalweight
(N/A)
80.06
(77.64)
-3.02% Details
8/12/2019 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
8/9/2019 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
8/9/2019 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/6/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/6/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
8/6/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/6/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
7/17/2019 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
7/15/2019 Unum Therapeutics UMRX Maintain Overweight
(N/A)
 
 
  Details
7/15/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
7/15/2019 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
7/15/2019 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
7/15/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/9/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
6/5/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
5/28/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
5/21/2019 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/8/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/1/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
4/29/2019 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
4/26/2019 Alexion Pharmaceuticals ALXn Maintain Overweight
(N/A)
 
 
  Details
4/9/2019 Biohaven Pharmaceutical Holding BHVN Downgrade Equalweight
(Overweight)
50.19
(14.66)
-70.79% Details
3/4/2019 Portola Pharmaceuticals PTLA Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Biohaven Pharmaceutical Holding BHVN Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 MacroGenics MGNX Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
2/26/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
2/25/2019 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
2/25/2019 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
2/25/2019 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
2/12/2019 Alexion Pharmaceuticals ALXN Maintain Overweight
(N/A)
 
 
  Details
2/8/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
1/30/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
1/30/2019 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
1/22/2019 Immunomedics IMMU Downgrade Equalweight
(Overweight)
13.31
(87.86)
560.11% Details
1/4/2019 argenx SE ARGX New Coverage Overweight
(N/A)
98.85
(375.36)
279.73% Details
1/2/2019 Moderna MRNA New Coverage Overweight
(N/A)
15.27
(177.09)
1059.72% Details
12/20/2018 DBV Technologies S.A DBVT Maintain Equalweight
(N/A)
 
 
  Details
11/7/2018 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
11/5/2018 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
11/5/2018 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/5/2018 Immunomedics IMMU New Coverage Overweight
(N/A)
24.03
(13.31)
-44.61% Details
11/2/2018 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
10/31/2018 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
10/29/2018 Kodiak Sciences Inc. KOD New Coverage Overweight
(N/A)
9.56
(7.38)
-22.8% Details
10/26/2018 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
10/24/2018 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Unum Therapeutics UMRX Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
10/11/2018 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
10/11/2018 Loxo Oncology LOXO Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
10/11/2018 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Evelo Biosciences Inc EVLO Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Biohaven Pharmaceutical Holding BHVN Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Alexion Pharmaceuticals ALXN Maintain Overweight
(N/A)
 
 
  Details
9/11/2018 DBV Technologies S.A DBVT Maintain Equalweight
(N/A)
 
 
  Details
9/10/2018 Voyager Therapeutics VYGR New Coverage Equalweight
(Overweight)
19.56
(5.63)
-71.22% Details
8/13/2018 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
8/13/2018 Rubius RUBY New Coverage Overweight
(N/A)
21.93
(0.21)
-99.04% Details